Schedule & Agenda

BIO Digital
Date
  • Show All
Time
  • Show All
  • Show All
  • Show All
Main Therapeutic Focus
  • Show All
Development Phase of Primary Product
  • Show All
Search Sessions
BIO Digital
Jump to Day
2 Results
Not Yet Scheduled
[Not Yet Scheduled]
Since the first FDA approved bispecific antibody Blincyto hit the market in 2015, a wave of new…
The American Society of Clinical Oncology’s (ASCO) Annual Meeting brings together more than 30,000…